Rising Cancer Incidence Fuels Growth In Cancer Profiling Market: A Key Catalyst Accelerating Global Cancer Profiling Market Growth in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cancer Profiling Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The global market dedicated to cancer profiling has experienced accelerated expansion recently, projected to advance from a valuation of $13.48 billion in the year 2024 to reach $15 billion by 2025, reflecting an 11.3% compound annual growth rate over the period; this upward trajectory during the historical timeframe is linked to several key factors, including the escalating frequency of cancer diagnoses, the broader integration of individualized medical strategies, greater utilization of biological markers in clinical settings, advancements in pharmaceutical creation and focused treatments, alongside heightened public awareness and proactive support from patient groups.

Cancer Profiling Market Size Forecast: What's the Projected Valuation by 2029?
The domain of cancer profiling is projected to experience swift expansion in the upcoming years, reaching a valuation of $22.97 billion by 2029, propelled by an 11.2% compound annual growth rate.This upward trajectory across the projection timeframe stems from several key factors such as the incorporation of artificial intelligence technologies, heightened international research partnerships, broadened use cases for liquid biopsies, increasing governmental backing for personalized medicine approaches, and greater societal focus on identifying diseases at premature stages.Key developments anticipated during this forecast interval involve the increasing prevalence of liquid biopsy techniques, the adoption of extensive genomic assessment methods, the growing importance of immunoprofiling, the formation of interconnected networks for sharing research data, and advances in single-cell sequencing technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

What Are the Drivers Transforming the Cancer Profiling Market?
The rising frequency of cancer is projected to fuel the expansion of the cancer profiling market moving ahead, where cancer incidence signifies the count of newly emerging cancer cases within a defined demographic across a set time frame; this surge in new cancer cases is attributed to factors such as increased urbanization, an expanding older population demographic, evolving personal habits, and influences from both the environment and genetics. Cancer profiling offers valuable assistance in determining particular molecular or hereditary alterations present within a neoplasm, including gene mutations or variations in the tumor's deoxyribonucleic acid, which proves beneficial throughout the entire cancer treatment process; to illustrate this, official estimates from the American Cancer Society, a non-profit entity based in the United States, indicated for the year 2022 that roughly 1.9 million new cancer diagnoses and an expected 609,360 fatalities due to cancer were anticipated throughout the United States, thereby confirming that greater cancer occurrence acts as a significant impetus for the growth trajectory of the cancer profiling market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

What Long-Term Trends Will Define the Future of the Cancer Profiling Market?
Leading firms within the cancer profiling sector are concentrating efforts on pioneering advancements, specifically aiming for extensive genomic coverage. This particular assay scrutinizes 517 genes associated with cancer across close to 30 different varieties of solid tumors. Extended coverage signifies an exhaustive examination of numerous genetic alterations, significant biomarkers, or molecular signatures. As an illustration of this progress, in March of 2022, Illumina, Incorporated, a biotechnology firm situated in the United States, introduced the TruSight Oncology Comprehensive (TSO) assay, representing a notable stride forward in diagnosing cancer. This recently introduced in vitro diagnostic tool in Europe analyzes cancer mutations to direct patients toward optimal targeted treatments; furthermore, it assesses both DNA and RNA for 517 genes spanning almost 30 solid tumor classifications. Providing results in just four to five days, this test hastens diagnosis and has obtained the CE mark, signifying adherence to European quality benchmarks, thereby decreasing the necessity to perform numerous separate gene tests on various tissue specimens.

Which Segments in the Cancer Profiling Market Offer the Most Profit Potential?
The cancer profilingmarket covered in this report is segmented -

1) By Technology: Immunoassays; PCR (Polymerized Chain Reaction); NGS (Next-Generation Sequencing); Microarrays; In-Situ Hybridization
2) By Biomarker Type: Genomic Biomarkers; Protein Biomarkers
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma Cancer; Other Cancers
4) By Application: Research Applications; Clinical Applications; Screening; Diagnostics; Prognostics; Other Applications

Subsegments:
1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Luminex xMAP Technology; Radioimmunoassays
2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR); Digital PCR (dPCR); Reverse Transcription PCR (RT-PCR)
3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES); Targeted Sequencing; RNA Sequencing (RNA-Seq)
4) By Microarrays: DNA Microarrays; RNA Microarrays; SNP Arrays
5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH); Chromogenic In-Situ Hybridization (CISH)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp

Which Firms Dominate the Cancer Profiling Market by Market Share and Revenue in 2025?
Major companies operating in the cancer profiling market include Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., Oncomine Dx Target Test, OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation

Which Regions Offer the Highest Growth Potential in the Cancer Profiling Market?
North America was the largest region in the cancer profiling market in 2024. The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.